Chemours Co. (NYSE:CC) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the stock. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $11.94.
A number of equities analysts have weighed in on the stock. Citigroup Inc. reissued a “neutral” rating and issued a $9.00 price objective (down from $10.50) on shares of Chemours in a research report on Friday, July 15th. Argus raised shares of Chemours from a “hold” rating to a “buy” rating and set a $13.00 price objective for the company in a research report on Wednesday, August 10th. They noted that the move was a valuation call. TheStreet raised shares of Chemours from a “sell” rating to a “hold” rating in a research report on Tuesday, August 9th. Jefferies Group upped their price objective on shares of Chemours from $10.00 to $15.00 and gave the company a “hold” rating in a research report on Thursday, September 1st. Finally, Zacks Investment Research raised shares of Chemours from a “hold” rating to a “strong-buy” rating and set a $14.00 price objective for the company in a research report on Wednesday, August 17th.
Chemours (NYSE:CC) opened at 14.93 on Wednesday. Chemours has a 12-month low of $3.06 and a 12-month high of $16.32. The stock’s market cap is $2.71 billion. The company’s 50 day moving average price is $14.44 and its 200-day moving average price is $10.48.
Chemours (NYSE:CC) last posted its quarterly earnings data on Tuesday, August 9th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.10. The company earned $1.38 billion during the quarter, compared to analysts’ expectations of $1.42 billion. Chemours had a negative net margin of 1.48% and a positive return on equity of 95.01%. The firm’s revenue for the quarter was down 8.3% on a year-over-year basis. During the same period in the prior year, the company posted ($0.10) EPS. On average, analysts forecast that Chemours will post $0.92 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Thursday, September 15th. Stockholders of record on Wednesday, August 17th were paid a $0.03 dividend. The ex-dividend date of this dividend was Monday, August 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.80%. Chemours’s dividend payout ratio (DPR) is presently -26.09%.
Several large investors have recently modified their holdings of CC. Advisor Partners LLC raised its stake in shares of Chemours by 5.0% in the second quarter. Advisor Partners LLC now owns 12,156 shares of the company’s stock worth $100,000 after buying an additional 580 shares during the period. Seaward Management Limited Partnership raised its stake in shares of Chemours by 16.3% in the second quarter. Seaward Management Limited Partnership now owns 12,568 shares of the company’s stock worth $103,000 after buying an additional 1,765 shares during the period. Williams Jones & Associates LLC raised its stake in shares of Chemours by 7.8% in the first quarter. Williams Jones & Associates LLC now owns 16,226 shares of the company’s stock worth $114,000 after buying an additional 1,169 shares during the period. Ameritas Investment Partners Inc. bought a new stake in shares of Chemours during the second quarter worth about $118,000. Finally, Winton Capital Group Ltd raised its stake in shares of Chemours by 1.3% in the second quarter. Winton Capital Group Ltd now owns 15,473 shares of the company’s stock worth $127,000 after buying an additional 194 shares during the period. Institutional investors and hedge funds own 76.63% of the company’s stock.
Chemours Company Profile
The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.
Receive News & Ratings for Chemours Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Co. and related companies with MarketBeat.com's FREE daily email newsletter.